← ANALYST RATINGS · TIPRANKS

Sotera Health (SHC): analyst forecast and price target

$17.89 −1.00% close 16.10.26 · market cap $5.2B · Healthcare · Medical - Diagnostics & Research
Price targets and ratings of

Analyst consensus

Moderate Buy

3 Buy0 Hold1 Sell

Ratings of 4 analysts in the last 3 months · top analysts only

12-month forecast

$21.75+21.6% upside

Based on 4 price targets given in the last 3 months, the average target is $21.75, the highest $24.00, the lowest $17.00. The average is +21.6% from the last price of $17.89.

$15.00$20.00Jan 26AprJulOctJan 27AprJulOctHigh$24.00Average$21.75Low$17.00
Highest target $24.00 Average target $21.75 Lowest target $17.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% J.P. Morgan $17.00 Sell −5.0% Downgrade 13.10.26on TipRanks Oct 14 06:06 +0.3%next day −1.6%
Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% Barclays $22.00 Buy +23.0% Reiterated 07.10.26on TipRanks 04:00 −1.7%next day 0.0% · 5 days 0.0%
Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% RBC Capital $24.00 Buy +34.2% Reiterated 06.10.26on TipRanks 21:45 −1.7%next day 0.0% · 5 days 0.0%
Evie Koslosky★★★★★★★★★★#9740 · hits 58% · avg −3.1% Goldman Sachs $24.00 Buy +34.2% Reiterated 20.09.26on TipRanks Sep 21 08:15 −1.7%next day 0.0% · 5 days −0.3%
Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% Piper Sandler $25.00 Buy +39.7% Reiterated 18.09.26on TipRanks 07:45 −1.3%next day −1.7% · 5 days −3.4%
Casey Woodring★★★★★★★★★★#2489 · hits 62% · avg +8.2% J.P. Morgan $18.00 Hold +0.6% Reiterated 10.08.26on TipRanks Aug 11 08:07 +0.6%next day +1.1% · 5 days −0.8%
Name not given — $23.00 → $25.00+8.7% Buy +39.7% Reiterated 07.08.26on TipRanks 07:01 −0.9%next day +0.6% · 5 days −0.2%
Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% Barclays $19.00 → $22.00+15.8% Buy +23.0% Reiterated 07.08.26on TipRanks 04:19 −0.9%next day +0.6% · 5 days −0.2%
Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% BMO Capital $20.00 → $22.00+10.0% Buy +23.0% Assigned 06.08.26on TipRanks Aug 7 08:10 +5.3%next day −0.9% · 5 days −0.6%
David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% Jefferies $19.50 Buy +9.0% Reiterated 20.11.25on TipRanks 09:00 +1.6%next day +2.4% · 5 days +6.0%
Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% KeyBanc — Hold — Reiterated 05.11.25on TipRanks 04:00 −4.1%next day +2.3% · 5 days +1.9%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Sotera Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%
1 year David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%
2 years David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%

Most profitable

3 months David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%
1 year David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%
2 years David Windley★★★★★★★★★★Jefferies · #769
Hits 59%292 of 495 Average return +9.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 06.10.26: target $22.86 at a price of $18.55 (+23.2%); now: $22.71 at $17.89 (+27.0%).

$18.00$20.00$22.00Sep 15Oct 1Oct 15Top analysts$21.75Average target$22.71Price$17.89

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051041Oct 2541Nov51Dec71Jan 269Feb8Mar18Apr36May381Jun271Jul72Aug61Sep611Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy332000
Buy687766
Hold011211
Sell000001

Earnings and sales forecast

Next report: 10.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.27 (from $0.26 to $0.27). Last quarter: $0.26.

Sales

Next quarter’s sales estimate — $320M (from $317M to $325M). Last quarter: $321M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Sotera Health
  • CEO: Alton E. Shader
  • Employees: 3,000
  • 9100 South Hills Boulevard, Broadview Heights, OH, 44147, US
  • soterahealth.com

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.

Data from the stock’s TipRanks forecast page, read 11 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗